Document:

Document

EXHIBIT 10.2

AMENDMENT TO EMPLOYMENT AGREEMENT
 
THIS AMENDMENT (this “Amendment”), dated March 4, 2021 and effective January 1, 2021 is made by and between VISHAY PRECISION GROUP, INC. a Delaware corporation (the “Company”) and WILLIAM CLANCY (the “Executive”).
WHEREAS, the Company and the Executive are parties to an employment agreement, dated November 17, 2010, as amended (the “Employment Agreement”); 
WHEREAS, Section 8.5 of the Employment Agreement provides that the Company and the Executive may amend the Employment Agreement by mutual agreement in writing; 
WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth herein (the “Amendment”); and 
NOW THEREFORE, in consideration of the premises and the mutual benefits to be derived herefrom and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
1.    Section 4.3 of the Employment Agreement is hereby amended in its entirety to read as follows:
“4.3    Long-Term Equity Incentives. Effective each January 1st during the Term, the Company shall grant Executive an annual equity award under the Company’s 2010 Stock Incentive Program (or any successor plan or arrangement thereof) having a value approximately equal to 75% of Executive’s Base Salary (or such higher percentage of Base Salary as determined by the Compensation Committee in its discretion) on such date (the “Annual Equity Grant”).  Commencing on January 1, 2021 and on each January 1 thereafter during the Term, fifty-percent (50%) of each Annual Equity Grant shall be in the form of time-vested restricted stock units (“RSUs”), and fifty-percent (50%) shall be in the form of performance-based restricted stock units (“PBRSUs”).  The number of shares of Common Stock subject to such RSUs and PBRSUs shall be determined by dividing the applicable amount of the Annual Equity Grant by the average closing price of Common Stock on the New York Stock Exchange for the five (5) consecutive trading days immediately preceding each January 1.  Subject to Executive’s continued employment with the Company, the RSUs and PBRSUs shall vest on January 1 of the third year following their grant, provided that, in the case of the PBRSUs, such PBRSUs shall vest only to the extent the performance criteria applicable to the PBRSUs are realized, with such performance criteria and extent of vesting established by the Compensation Committee, it being agreed that the impact of acquisitions by the Company shall be included in calculating the achievement of the applicable performance criteria.  In the event of the termination of Executive’s employment with the Company by the Company without Cause, by Executive for Good Reason, or as a result of Executive’s death or Disability, and subject to the Executive’s (or his legal representative’s 

execution in the case of death) executing and not revoking the Release contemplated in Section 6.3, the outstanding RSUs granted pursuant to this Section 4.3 shall immediately vest and the outstanding PBRSUs granted pursuant to this Section 4.3 shall vest on their normal vesting date to the extent the applicable performance criteria are realized.  In the event of a Change in Control, all of such outstanding RSUs and PBRSUs shall immediately vest.”
2.    Except as set forth in this Amendment, all other terms and conditions of the Employment Agreement shall remain unchanged and in full force and effect.
3.    This Amendment may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original and all of which shall constitute the same instrument.
IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its duly authorized officer, and Executive has executed this Amendment, in each case on the 4th day of March, 2021.

VISHAY PRECISION GROUP, INC.

By:    /s/ Ziv Shoshani
Ziv Shoshani
Title:    President and Chief Executive Officer

                                            

    
/s/ William Clancy
WILLIAM CLANCY

                            

-2-Document

EXHIBIT 10.3

AMENDMENT TO EMPLOYMENT AGREEMENT
 
THIS AMENDMENT (this “Amendment”), dated March 4, 2021 and effective January 1, 2021 is made by and between VISHAY ADVANCED TECHNOLOGIES, LTD (the “Company”), a corporation organized under the laws of the State of Israel and a wholly-owned subsidiary of VISHAY PRECISION GROUP, INC. a Delaware corporation (“VPG”), (the “Company”) and AMIR TAL (the “Executive”).
WHEREAS, the Company and the Executive are parties to an employment agreement, dated March 15, 2020, as amended (the “Employment Agreement”); 
WHEREAS, Section 8.5 of the Employment Agreement provides that the Company and the Executive may amend the Employment Agreement by mutual agreement in writing; 
WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth herein (the “Amendment”); and 
NOW THEREFORE, in consideration of the premises and the mutual benefits to be derived herefrom and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
1.    Section 4.3 of the Employment Agreement is hereby amended in its entirety to read as follows:
“4.3    Long-Term Equity Incentives.  Effective each January 1st  during the Term, the Company shall grant Executive an annual equity award under the Company’s 2010 Stock Incentive Program (or any successor plan or arrangement thereof) having a value approximately equal to 40% of Base Salary (or such higher percentage of Base Salary as determined by the Compensation Committee in its discretion) on such date (the “Annual Equity Grant”).  Commencing on January 1, 2021 and on each January 1 thereafter during the Term, fifty-percent (50%) of each Annual Equity Grant shall be in the form of time-vested restricted stock units (“RSUs”), and fifty-percent (50%) shall be in the form of performance-based restricted stock units (“PBRSUs”).  In the event of the termination of Executive’s employment with the Company by the Company without Cause, by Executive for Good Reason, or as a result of Executive’s death or Disability, and subject to the Executive’s (or his legal representative’s execution in the case of death) executing and not revoking the Release contemplated in Section 6.3, any outstanding time-vested Annual Equity Grants awarded pursuant to this Section 4.3 shall immediately vest and any outstanding performance vested Annual Equity Grants awarded pursuant to this Section 4.3 shall vest on their normal vesting date to the extent the applicable performance criteria are realized. In the event of a Change in Control, all of such outstanding Annual Equity Grants shall immediately vest provided Executive is actively employed by the Company on the closing date of such event.”

2.    Except as set forth in this Amendment, all other terms and conditions of the Employment Agreement shall remain unchanged and in full force and effect.
3.    This Amendment may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original and all of which shall constitute the same instrument.
IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its duly authorized officer, and Executive has executed this Amendment, in each case on the 4th day of March, 2021.

VISHAY ADVANCED TECHNOLOGIES, LTD

By:    /s/ Ziv Shoshani
Ziv Shoshani
Title:    President and Chief Executive Officer

/s/ Amir Tal
AMIR TAL

    

                            

-2-Exhibit
10.1

 

Zoetis Inc.

10 Sylvan Way

Parsippany, NJ 07054

 

May 5, 2021

 

Mr. Wetteny Joseph

 

Dear Wetteny,

 

On behalf of Zoetis, Kristin Peck and
I are delighted to extend to you an offer to join Zoetis in the position of Executive Vice President, Chief Financial Officer and Head
of Business Development.

 

All who interviewed you were impressed
by your background and experience and we look forward to you making a significant contribution to our Company.

 

This letter confirms the terms of the
offer.

 

Annual Base Salary:

 

$675,000, payable bi-weekly.

 

Annual Bonus:

 

You are eligible to participate in our
Zoetis Annual Incentive Plan (ZAIP). As a ZAIP participant, you will work with your manager each year to develop ZAIP objectives. Your
target annual incentive will be 80% of your base salary. Please note that bonuses under the ZAIP are discretionary, and that neither
this letter, nor your target incentive, constitutes a guarantee that you will receive a bonus of any particular amount.

 

Your ZAIP bonus for 2021 will be payable
in March of 2022, pending approval by the Human Resources Committee of the Board of Directors of Zoetis (the “HR Committee”),
and will be based on factors such as Zoetis’ performance, your functions’ performance, and your individual performance as
assessed by your manager. Your annual bonus payout may vary from 0-200% of target based on business performance and your individual performance,
subject to the overall bonus pool funding based on Zoetis Inc. performance.

 

Long Term
Incentive:

 

You are eligible to participate in Zoetis’
Long-Term Incentive (LTI) Program, and your 2022 target LTI award will be $2,200,000. The program is designed to recognize performance
and encourage long-term commitment to Zoetis with discretionary share-based rewards. Share-based awards must be approved by the HR Committee.
Each award is an independent “stand-alone” event without any connection in terms of eligibility or amount as compared to prior
or future grants. Award eligibility is determined on an annual basis with consideration of external market data as well as internal business
drivers. Awards are governed by federal and state law, the requirements of the New York Stock Exchange, and the terms and conditions set
forth in the Zoetis Equity and Incentive Plan (“Plan”) documents.

 

Sign-On Bonus:

 

You will receive a cash sign-on payment
of $2,000,000. This is a one-time payment that is subject to supplemental income tax rates. Payment will be made within thirty
(30) days following your start date. In the event that you are terminated for Cause, you agree to repay the sign-on bonus. By accepting
this offer, you agree to repay Zoetis the full amount owed, if you are terminated for Cause, within thirty (30) days of your last day
of work or as otherwise agreed to with Zoetis.

 

    

     

    

 

Sign-On LTI
Award:

 

In addition, you will be granted a one-time sign-on LTI award
with a grant date value of $5,100,000. This award will be made in the form of Zoetis Restricted Stock Units
(“RSUs”) and will be granted on the last trading day of the month that includes your date of hire. Zoetis share-based
awards, including these RSUs, generally vest 100% on the third anniversary of the grant date, assuming your continued employment by
Zoetis through that date. As we discussed, $1,400,000 of this sign-on award will be non-forfeitable in the event of your termination
of employment with Zoetis for any reason other than for Cause. In addition, this share-based award will be governed by the terms and
conditions set forth in your LTI Award Agreement and the Plan documents. The Plan document and a sample LTI Award Agreement will be
sent to you under separate cover.

 

 Vacation:

 

In addition to Company-paid holidays,
you are entitled 4 weeks of annual vacation.

 

 Benefits:

 

You will also be eligible to participate
in Zoetis’ benefits program as described in the accompanying benefits document.  Benefit coverage will commence on your start
date.  You will receive complete details and enrollment information within your first week of employment.  Your participation
in Zoetis’ benefit programs is subject to the terms and conditions of each program, as described in greater detail in the plan documents
and summary plan descriptions.  The benefits programs are subject to change by Zoetis in its discretion.

 

Severance:

 

As a member of the Zoetis Executive Team,
you will be covered under the terms and conditions of the Zoetis Executive Severance Plan. A copy of the Executive Severance Plan will
be sent to you under separate cover.

 

Pre-Employment Contingencies:

 

In accordance with Zoetis policy, and
as set forth above, this employment offer is contingent upon successful completion of all aspects of Zoetis’ pre-employment screening
process. This process includes the verification of information you provide to us for a background check as well as your successful completion
of a drug screen to detect the presence of illegal drugs.

 

Background Verification Process (BVP)
- This program will verify the information you have provided concerning your prior employment and education. Also, as a responsible employer
concerned with the security of our customers, employees, business partners and the general public, we will perform a criminal history
check to determine whether there are criminal convictions of record and verify your identity. Once you have notified us of that you have
accepted this offer of employment, you will receive an e-mail prompt from HireRight who will coordinate the investigation.

 

Pre-Employment Drug Screen – All
new hire applicants must complete a pre-employment drug screen prior to the commencement of employment. Once you have notified us of that
you have accepted this offer of employment, you will receive an e-mail prompt from HireRight within 48 hours of offer acceptance to schedule
your pre-employment drug test. The drug screen must be completed within 5 days of offer acceptance. 

 

Employment
Eligibility Verification:

 

As required by current US immigration
law, this offer is contingent upon your ability to satisfy the Form I-9 requirements at the time that you commence work in the US or within
3 business days of the date your employment begins. This requires you to establish your identity and to prove that you have legal authorization
to work for Zoetis in the US. In the event that you do not have legal authorization to work for Zoetis in the US, and that you are unable
to secure such employment authorization by the time that you are scheduled to commence work, Zoetis will not be able to hire you and this
offer of employment will therefore be revoked. If you have started work but fail to provide acceptable I-9 documentation your employment
will be immediately terminated.

 

Also in considering this offer, if
you are accepting employment as a nonimmigrant who is authorized to work in the US, it will be your responsibility to work with
Zoetis’ Immigration Team to ensure that your work authorization remains current and that when you travel you secure proper
travel documents to avoid problems re-entering the U.S. Your failure to manage these important matters could result in Zoetis’
inability to continue your employment. Moreover, Zoetis makes no promise or representation in this offer of employment to support
extensions of your nonimmigrant work authorization or to support your application for permanent residency in the US. These decisions
are made by your management, human resources and Zoetis Immigration Team on an individual basis. You should consider this carefully
before deciding to accept this offer.

 

    

     

    

 

Employment At-Will:

 

This letter, and its accompanying documents,
set out the complete terms of our offer of employment but are not intended as and should not be considered a contract of employment for
a fixed period of time. If you accept this offer of employment with the Company you accept that your employment is at-will, which means
that you or Zoetis are free to end the employment relationship at any time, with or without cause. Any amendments to this letter must
be in writing.

 

Your start date is expected to be no later than June 15, 2021.

 

To accept this offer, please sign this
letter and return it to me. Please also retain a copy for your records. If you have any questions about this offer, please contact me
at roxanne.lagano@zoetis.com. Please note this offer expires at the close of business on May 7, 2021.

 

Wetteny, we are so excited to have you
join Zoetis and I very much look forward to working with you.

 

Best regards,

 

Roxanne Lagano

EVP, Chief Human Resources Officer and
Global Operations

 

Accepted:

  

	/s/ Wetteny Joseph	 	May 6, 2021
	Wetteny Joseph	 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}]]